Quick Answer
Fortress Biotech, Inc. reported Net Income of $6.82 million for fiscal year 2025.
Fortress Biotech, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $6.82M | +114.8% |
| 2024 | -$46.00M | +24.1% |
| 2023 | -$60.64M | +30.0% |
| 2022 | -$86.58M | -33.8% |
| 2021 | -$64.70M | -39.1% |
| 2020 | -$46.53M | -16.4% |
| 2019 | -$39.96M | +52.5% |
| 2018 | -$84.15M | -25.8% |
| 2017 | -$66.88M | -21.4% |
| 2016 | -$55.09M | -13.8% |
| 2015 | -$48.43M | -137.6% |
| 2014 | -$20.39M | +45.1% |
| 2013 | -$37.16M | -34.6% |
| 2012 | -$27.61M | +24.1% |
| 2011 | -$36.36M | -264.3% |
| 2010 | -$9.98M | -172.3% |
| 2009 | -$3.67M | +3.5% |
| 2008 | -$3.80M | -43.7% |
| 2007 | -$2.64M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.85M | +145.5% | -62.2% |
| June 30, 2025 | $15.49M | +241.5% | +246.3% |
| March 31, 2025 | -$10.58M | +31.3% | +17.7% |
| September 30, 2024 | -$12.87M | -155.0% | -17.5% |
| June 30, 2024 | -$10.95M | +55.8% | +29.0% |
| March 31, 2024 | -$15.42M | +28.4% | -205.6% |
| September 30, 2023 | -$5.04M | +77.6% | +79.6% |
| June 30, 2023 | -$24.78M | -16.0% | -15.0% |
- Fortress Biotech, Inc. showed an increase of +114.8% in Net Income compared to the prior fiscal year.
- Over the 2007–2025 period, Fortress Biotech, Inc.’s net income has grown by 357.8% (from -$2.64 million to $6.82 million).
- The most recent figure is from Fortress Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: